1. Saadia D, Voustianiouk A, Wang AK, Kaufmann H. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology. 2001 Dec 11;57(11):2095-9. doi: 10.1212/wnl.57.11.2095. PMID: 11739832.
2. Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ. 2005 Jan 4;172(1):69-75. doi: 10.1503/cmaj.1040708. PMID: 15632408; PMCID: PMC543948.
3. Wong NS, Adlam TM, Potts GA, Farshchian M. Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics. Dermatol Ther (Heidelb). 2022 Dec;12(12):2705-2714. doi: 10.1007/s13555-022-00838-3. Epub 2022 Nov 3. PMID: 36329359; PMCID: PMC9674821.
4. Peel JS, McNarry MA, Heffernan SM, Nevola VR, Kilduff LP, Waldron M. Measurement of thermal sweating at rest and steady-state exercise in healthy adults: Inter-day reliability and relationships with components of partitional calorimetry. PLoS One. 2022 Dec 1;17(12):e0278652. doi: 10.1371/journal.pone.0278652. PMID: 36455061; PMCID: PMC9714830.
5. Eisenach JH, Atkinson JL, Fealey RD. Hyperhidrosis: evolving therapies for a well-established phenomenon. Mayo Clin Proc. 2005 May;80(5):657-66. doi: 10.4065/80.5.657. Erratum in: Mayo Clin Proc. 2005 Jun;80(6):828. PMID: 15887434.
doi:10.4065/80.5.657.
6. Grabell DA, Hebert AA. Current and Emerging Medical Therapies for Primary Hyperhidrosis. Dermatol Ther (Heidelb). 2017 Mar;7(1):25-36. doi: 10.1007/s13555-016-0148-z. Epub 2016 Oct 27. PMID: 27787745; PMCID: PMC5336423.
7. McConaghy JR, Fosselman D. Hyperhidrosis: Management Options. Am Fam Physician. 2018 Jun 1;97(11):729-734. PMID: 30215934.
8. Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol. 2001 Aug;145(2):289-93. doi: 10.1046/j.1365-2133.2001.04349.x. PMID: 11531794.
9. MacMillan F, Reller HH, Synder FH. The antiperspirant action of topically applied anticholinergics. J Invest Dermatol. 1964 Nov;43:363-77. doi: 10.1038/jid.1964.167. PMID: 14216513.
10. Odukoya OA, Ilori OO, Sofidiya MO. Astringent herbs as vasoconstrictors in haemorrhoid therapy. Planta Med. 2007;73(09):231. doi: 10.1055/s-2007-987012.
11. Khanbabaee K, van Ree T. Tannins: classification and definition. Nat Prod Rep. 2001 Dec;18(6):641-9. doi: 10.1039/b101061l. PMID: 11820762.
12. Chroho M, Bouymajane A, Oulad El Majdoub Y, Cacciola F, Mondello L, Aazza M, et al. Phenolic composition, antioxidant and antibacterial activities of extract from flowers of Rosa damascena from morocco. Separations. 2022 Sep 5;9(9):247. doi: 10.3390/separations9090247.
13. Awale S, Tohda C, Tezuka Y, Miyazaki M, Kadota S. Protective Effects of Rosa damascena and Its Active Constituent on Aβ(25-35)-Induced Neuritic Atrophy. Evid Based Complement Alternat Med. 2011;2011:131042. doi: 10.1093/ecam/nep149. Epub 2011 Aug 21. PMID: 19789212; PMCID: PMC3162985.
14. Rahimi M, Ghoreshi M, Emami B, Shafei MN, Hosseini M, Khajavirad A. Preventive Effect of Hydroalcoholic Extract of Rosa damascena on Cardiovascular Parameters in Acute Hypertensive Rats Induced by Angiotensin II. Int J Prev Med. 2018 Oct 12;9:92. doi: 10.4103/ijpvm.IJPVM_312_17. PMID: 30450175; PMCID: PMC6202776.
15. Bozcheloei MI, Sani MG, Sedaghat K, Jarrahi M, Nejat H, Khorasani MZ. The Effect of Hydro-Alcoholic Extract of Rosa damascena on Uterine Constriction of Virgin Rats. Middle East J Rehabil Health Stud. 2017;4(3) ; e13089. doi: 10.5812/mejrh.13089.
16. Hajhashemi V, Ghannadi A, Hajiloo M. Analgesic and Anti-inflammatory Effects of Rosa damascena Hydroalcoholic Extract and its Essential Oil in Animal Models. Iran J Pharm Res. 2010 Spring;9(2):163-8. PMID: 24363723; PMCID: PMC3862064.
17. Dabbaghi MM, Fadaei MS, Soleimani Roudi H, Baradaran Rahimi V, Askari VR. A review of the biological effects of Myrtus communis. Physiol Rep. 2023 Jul;11(14):e15770. doi: 10.14814/phy2.15770. PMID: 37464095; PMCID: PMC10354007.
18. Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacological effects of Myrtus communis L. and its active constituents. Phytother Res. 2014 Aug;28(8):1125-36. doi: 10.1002/ptr.5122. Epub 2014 Feb 4. Erratum in: Phytother Res. 2021 Aug;35(8):4626. doi: 10.1002/ptr.6993. PMID: 24497171.
19. Aslani A, Zolfaghari B, Davoodvandi F. Design, Formulation and Evaluation of an Oral Gel from Punica Granatum Flower Extract for the Treatment of Recurrent Aphthous Stomatitis. Adv Pharm Bull. 2016 Sep;6(3):391-398. doi: 10.15171/apb.2016.051. Epub 2016 Sep 25. PMID: 27766223; PMCID: PMC5071802.
20. Zafar F, Jahan N, Ali S, Jamil S, Hussain R, Aslam S. Enhancing pharmaceutical potential and oral bioavailability of Allium cepa nanosuspension in male albino rats using response surface methodology. Asian Pac J Tropical Biomed. 2022 Jan 1;12(1):26-38. doi: 10.4103/2221-1691.331792.
21. Gobetti C, Bitencourt AD, Ayres MV, Freitas AL, Mendez AS, Garcia CV. Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets-a Hospital concern. Braz J Pharm Sci. 2021 Oct 11;57:e18896 doi:10.1590/s2175-97902020000418896.
22. Ceulemans J, Ludwig A. Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques. Eur J Pharm Biopharm. 2002 Jul;54(1):41-50. doi: 10.1016/s0939-6411(02)00036-x. PMID: 12084501.
23. Coss E, Kealey C, Brady D, Walsh P. A laboratory investigation of the antimicrobial activity of a selection of western phytomedicinal tinctures. Eur J Integr Med. 2018 Apr 1;19:80-83. doi:10.1016/j.eujim.2018.02.008.
24. Mwankuna CJ, Mariki EE, Mabiki FP, Malebo HM, Styrishave B, Mdegela RH. Thin layer chromatographic method for detection of conventional drug adulterants in herbal products. Separations. 2023 Dec 31;10(1):23. doi:10.3390/separations10010023.
25. Ainsworth EA, Gillespie KM. Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent. Nat Protoc. 2007;2(4):875-7. doi: 10.1038/nprot.2007.102. PMID: 17446889.
26. Moein M, Zarshenas M, Etemadfard H. Essential oil composition and total flavonoid content of Aloysia citriodora Palau under different cultivation systems. Int J Plant Anim Environ Sci. 2014;4(1):353-8.
27. Polshettiwar SA, Ganjiwale RO, Wadher SJ, Yeole PG. Spectrophotometric estimation of total tannins in some ayurvedic eye drops. Indian J Pharm Sci. 2007 Jul 1;69(4). doi: 10.4103/0250-474X.36949.
28. Nalbandian RM, Henry RL, Balko KW, Adams DV, Neuman NR. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. J Biomed Mater Res. 1987 Sep;21(9):1135-48. doi: 10.1002/jbm.820210907. PMID: 3667639.
29. Sheridan RL, Tompkins RG. Skin substitutes in burns. Burns. 1999 Mar;25(2):97-103. doi: 10.1016/s0305-4179(98)00176-4. PMID: 10208382.
30. Wysocki AB. Skin anatomy, physiology, and pathophysiology. Nurs Clin North Am. 1999 Dec;34(4):777-97, v. PMID: 10523436.
31. Thomas I, Brown J, Vafaie J, Schwartz RA. Palmoplantar hyperhidrosis: a therapeutic challenge. Am Fam Physician. 2004 Mar 1;69(5):1117-20. PMID: 15023010.
32. Shelley WB, Hurley HJ Jr. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol. 1975;55(4):241-60. PMID: 52254.
33. Hölzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol. 1984 Apr;110(4):399-403. doi: 10.1111/j.1365-2133.1984.tb04653.x. PMID: 6712884.
34. Guillard O, Fauconneau B, Olichon D, Dedieu G, Deloncle R. Hyperaluminemia in a woman using an aluminum-containing antiperspirant for 4 years. Am J Med. 2004 Dec 15;117(12):956-9. doi: 10.1016/j.amjmed.2004.07.047. PMID: 15629736.
35. Darbre PD. Aluminium, antiperspirants and breast cancer. J Inorg Biochem. 2005 Sep;99(9):1912-9. doi: 10.1016/j.jinorgbio.2005.06.001. PMID: 16045991.
36. Tomljenovic L. Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link? J Alzheimers Dis. 2011;23(4):567-98. doi: 10.3233/JAD-2010-101494. PMID: 21157018.
37. Azadbakht M, Akbari J, Pasandi S. Formulation of herbal antiperspirant from Parotia persica (DC.) C.A.Mey. (Hamamelis persica) and preliminary clinical study. J Med Plants. 2004;3(9):35-42.
38. Scalbert A. Antimicrobial properties of tannins. Phytochemistry. 1991;30(12):3875-883. doi: 10.1016/0031-9422(91)83426-L.
39. Wang ZL. Nanostructures of zinc oxide. Mater Today. 2004;7(6):26-33. doi: 10.1016/S1369-7021(04)00286-X.
40. Kaviyarasu K, Geetha N, Kanimozhi K, Maria Magdalane C, Sivaranjani S, Ayeshamariam A, et al. In vitro cytotoxicity effect and antibacterial performance of human lung epithelial cells A549 activity of Zinc oxide doped TiO2 nanocrystals: Investigation of bio-medical application by chemical method. Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:325-333. doi: 10.1016/j.msec.2016.12.024. Epub 2016 Dec 9. PMID: 28254301.
41. Teerasumran P, Velliou E, Bai S, Cai Q. Deodorants and antiperspirants: New trends in their active agents and testing methods. Int J Cosmet Sci. 2023 Aug;45(4):426-443. doi: 10.1111/ics.12852. Epub 2023 Mar 21. PMID: 36896776; PMCID: PMC10946881.
42. Huang MY, Liao MH, Wang YK, Huang YS, Wen HC. Effect of lavender essential oil on LPS-stimulated inflammation. Am J Chin Med. 2012;40(4):845-59. doi: 10.1142/S0192415X12500632. PMID: 22809036.
43. Hohmann J, Zupkó I, Rédei D, Csányi M, Falkay G, Máthé I, et al. Protective effects of the aerial parts of Salvia officinalis, Melissa Officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med. 1999 Aug;65(6):576-8. doi: 10.1055/s-2006-960830. PMID: 10532875.
44. Gharavi M, K. Shokraei K, Formulation, Assessment and Comparsion of Two Antiperspirants Containing Aluminum Chlorohydrate and Gallic Acid. Pharm Sci. 2000;3:63-68.